2.6900
-0.2300
(-7.88%)
At close: January 10 at 4:00:00 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 560.5k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
Arena (Joseph) Director of Issuer | Acquisition or disposition in the public market at price 1.97 per share. | Direct | 4,925 | Oct 21, 2022 |
Svoronos (Dawn A) Director of Issuer | -- | Direct | -- | Oct 20, 2022 |
Lafond (Jocelyn) Senior Officer of Issuer | Acquisition or disposition in the public market at price 2.21 per share. | Direct | 1,765 | Jul 21, 2022 |
Lafond (Jocelyn) Senior Officer of Issuer | Acquisition or disposition in the public market at price 2.20 per share. | Direct | 13,633 | Jul 21, 2022 |
Lafond (Jocelyn) Senior Officer of Issuer | Acquisition or disposition in the public market at price 2.21 per share. | Direct | 6,645 | Jul 21, 2022 |
Lafond (Jocelyn) Senior Officer of Issuer | Exercise of options at price 0.29 per share. | Direct | 5,900 | Jul 19, 2022 |
Lafond (Jocelyn) Senior Officer of Issuer | Acquisition or disposition in the public market at price 2.14 per share. | Direct | 6,411 | Jul 19, 2022 |
Lafond (Jocelyn) Senior Officer of Issuer | -- | Direct | -- | Jul 19, 2022 |
Holler (Frank A) Director of Issuer | Acquisition or disposition in the public market at price 2.54 per share. | Direct | 99,177 | May 3, 2022 |
Arena (Joseph) Director of Issuer | Acquisition or disposition in the public market at price 2.27 per share. | Direct | 11,098 | May 2, 2022 |
Arena (Joseph) Director of Issuer | Acquisition or disposition in the public market at price 2.31 per share. | Direct | 230 | May 2, 2022 |
Related Tickers
ONC.TO Oncolytics Biotech Inc.
1.2500
-3.85%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
APS.TO Aptose Biosciences Inc.
0.3150
+1.61%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
ENGN enGene Holdings Inc.
7.61
-6.05%
COV.V Covalon Technologies Ltd.
3.2000
+3.23%
BCTXW BriaCell Therapeutics Corp.
0.1600
-17.91%
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
ONCY Oncolytics Biotech Inc.
0.8696
+0.18%
APRE Aprea Therapeutics, Inc.
3.6550
-7.47%